Funded Grants

Grants awarded in the current fiscal year and carried over from prior fiscal years.

PI Name Sort descending	PI Organization	Title	Grant Number	Initiative	Program Official
Huttenhower, Curtis	Broad Institute, Inc. United States	PROSPECT: Pathways, Risk factors, and mOleculeS to Prevent Early-onset Colorectal Tumors	3OT2CA297578-01S1		Asad Umar, D.V.M., Ph.D.
Ibsen, Stuart Duncan	Oregon Health & Science University United States	Distinguishing Pancreatic Cancer from Benign Pancreatic Disease using Nanoparticle-based Biomarkers	5R37CA258787-05		Matthew Young, Ph.D.
Im, Eun-Ok	University Of Texas At Austin United States	Cancer Pain Management: A Technology-Based Intervention for Asian American Breast Cancer Survivors	5R33CA280979-04		Brennan Streck, Ph.D., RN, M.P.H.
Infante, Rodney E	Ut Southwestern Medical Center United States	Identifying the Cellular and Molecular Targets of JAK/STAT-Driven Adipose Wasting to Reverse Cancer Cachexia	3R01CA266900-04S1	PA-20-185 (Parent R01 Clinical Trial Not Allowed)	Marjorie Perloff, M.D.
Irvin, William J	Southeast Clinical Oncol Res Consortium United States	NCI Community Oncology Research Program 2025 Extension Request	3UG1CA189858-11S1		Vanessa A. White, M.P.H.
Iwelunmor, Juliet	Washington University United States	Innovative Rapid Enabling, Affordable, point-of-Care HPV Self-Testing Strategy (I-REACH)	3U01CA279863-04S1		Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Iyer, Prasad G.	Mayo Clinic Arizona United States	Minimally Invasive Molecular Approaches for the Detection of Barrett’s Esophagus and Esophageal Adenocarcinoma	2R01CA241164-07		Matthew Young, Ph.D.
Jacob, Jennifer B	Henry Ford Health + Michigan State University Health Sciences United States	Defining Cancer Intervention Targets by Functional Genomics Analysis of Outbred F1 Mice	5R01CA278818-03		Anda Vlad, M.D., Ph.D.
James, Aimee S	Washington University United States	Siteman Cancer Center Catchment CSRN ACCESS Hub	5UG1CA286946-03		Elyse LeeVan, M.D., M.P.H.
Jang, Mi-Hyeon	Rutgers Biomedical And Health Sciences United States	Identification of novel biomarkers and therapeutic strategies in chemobrain.	5R01CA293210-02		John Clifford, Ph.D.